BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Dutch Cancer Patients To Benefit From Erasmus Medical Center Daniel den Hoed Cancer Center’s New Treatment Technology

  June 2, 2014

   · 

  2 min read
• Drug Development

  Millennium Release: VELCADE®: (Bortezomib)-Based Therapy Significantly Improved Progression-Free Survival Compared To Standard Therapy As Frontline Treatment Of Patients With Mantle Cell Lymphoma In Phase 3 Study

  June 2, 2014

   · 

  1 min read
• Drug Development

  Aquinox Pharmaceuticals Announces Expansion Of Ongoing Phase 2 Trials Of AQX-1125, Including Acceptance Of U.S. IND

  June 2, 2014

   · 

  1 min read
• Pharm Country

  Mylan Inc. Settles Patent Litigation Related To Celebrex® Capsules

  June 2, 2014

   · 

  2 min read
• Drug Development

  Celgene Release: Post-Hoc Analysis Of Overall Survival In Phase III MPACT Study Of Patients With Advanced Pancreatic Cancer Presented At American Society of Clinical Oncology 2014

  June 2, 2014

   · 

  1 min read
• Biotech Beach

  Biocept, Inc. Expands Breast Cancer Offering

  June 2, 2014

   · 

  1 min read
• Policy

  Immucor Announces Lifting Of FDA NOIR

  June 2, 2014

   · 

  1 min read
• Deals

  Ohr Pharmaceutical Announces Closing Of SKS Ocular Acquisition; Strengthens Executive Management Team

  June 2, 2014

   · 

  1 min read
• Business

  Mesa Labs Reports Record Net Income And Revenues

  June 2, 2014

   · 

  1 min read
• Drug Development

  Merrimack Pharmaceuticals Inc. Identifies Heregulin As Patient Response Biomarker For MM-121 And Standard Of Care Therapy Across Multiple Cancers

  June 2, 2014

   · 

  1 min read